Villar, J. et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID multinational cohort study. JAMA Pediatr. 175, 817–826 (2021).
Vouga, M. et al. Maternal outcomes and risk factors for COVID-19 severity among pregnant women. Sci. Rep. 11, 13898 (2021).
Takemoto, M. L. S. et al. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int. J. Gynaecol. Obstet. 151, 154–156 (2020).
Brendolin, M. et al. Severe maternal morbidity and mortality during the COVID-19 pandemic: A cohort study in Rio de Janeiro. IJID Reg. 6, 1–6 (2023).
Estes, M. L. & McAllister, A. K. Maternal immune activation: Implications for neuropsychiatric disorders. Science 353, 772–777 (2016).
Han, V. X., Patel, S., Jones, H. F. & Dale, R. C. Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat. Rev. Neurol. 17, 564–579 (2021).
Than, N. G., Hahn, S., Rossi, S. W. & Szekeres-Bartho, J. Editorial: Fetal-Maternal immune interactions in pregnancy. Front. Immunol. 10, 2729 (2019).
Atladóttir, H., Henriksen, T. B., Schendel, D. E. & Parner, E. T. Autism after infection, febrile episodes, and antibiotic use during pregnancy: An exploratory study. Pediatrics 130, e1447-1454 (2012).
Brown, A. S. Prenatal infection as a risk factor for schizophrenia. Schizophr. Bull. 32, 200–202 (2006).
Brown, A. S. et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 61, 774–780 (2004).
Chess, S. Autism in children with congenital rubella. J. Autism Child. Schizophr. 1, 33–47 (1971).
Cordeiro, C. N., Tsimis, M. & Burd, I. Infections and brain development. Obstet. Gynecol. Surv. 70, 644–655 (2015).
Solek, C. M., Farooqi, N., Verly, M., Lim, T. K. & Ruthazer, E. S. Maternal immune activation in neurodevelopmental disorders. Dev. Dyn. 247, 588–619 (2018).
Calvert, C. et al. Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries. Nat. Hum. Behav. 7, 529–544 (2023).
Torche, F. & Nobles, J. Vaccination, immunity, and the changing impact of COVID-19 on infant health. Proc. Natl. Acad. Sci. U. S. A. 120, e2311573120 (2023).
Smith, L. H., Dollinger, C. Y., VanderWeele, T. J., Wyszynski, D. F. & Hernández-Díaz, S. Timing and severity of COVID-19 during pregnancy and risk of preterm birth in the international registry of coronavirus exposure in pregnancy. BMC Pregnancy Childbirth 22, 775 (2022).
Hee Chung, E., Chou, J. & Brown, K. A. Neurodevelopmental outcomes of preterm infants: A recent literature review. Transl. Pediatr. 9, S3-s8 (2020).
Foo, S.-S. et al. The systemic inflammatory landscape of COVID19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in-utero SARS-CoV-2. Cell Rep. Med. 2, 100453 (2021).
Cambou, M. C. et al. Longitudinal Evaluation of antibody persistence in mother-infant dyads after severe acute respiratory syndrome coronavirus 2 infection in pregnancy. J. Infect. Dis. 227, 236–245 (2022).
Fajardo Martinez, V. et al.…
Read More: Neurodevelopmental delay in children exposed to maternal SARS-CoV-2 in-utero